Progyny: Pay

Progyny paid its 5 named executives $15.8M in total in FY2025 (Dec). CEO Peter Anevski was paid $7.2M of that.

Pay$100 in the stock at the end of FY20 → $61
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Peter AnevskiChief Executive Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Melissa CummingsChief Operating Officer
FY2025 (Dec)
1 year
Mark LivingstonChief Financial Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Geoffrey ClappChief Product Officer
FY2025 (Dec)
1 year
Allison SwartzEVP, General Counsel and Secretary
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
4 years

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 9 peers with pay on file was $11.2M. The CEO of Progyny was paid $7.2M, 36% below the median.

  1. 1Astrana Health
  2. 2Evolent Health
  3. 3RadNet
  4. 4QuidelOrtho
  5. 5Teladoc Health
  6. 6Sotera Health
  7. 7Healthequity
  8. 8Progyny
  9. 9Repligen
  10. 10Corvel
  11. 11Alignment HealthcareNot disclosed
  12. 12Azenta, Inc.Not disclosed
  13. 13CertaraNot disclosed
  14. 14HaemoneticsNot disclosed
  15. 15Masimo CorporationNot disclosed
  16. 16NeoGenomics, Inc.Not disclosed
  17. 17OmnicellNot disclosed
  18. 18Premier, Inc.Not disclosed
  19. 19Privia Health GroupNot disclosed
  20. 20R1 RCM Inc.Not disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.